洛伦德罗斯塔特在不受控制的高血压中的有效性和安全性:一个元分析
Alaa Abdrabou Abouelmagd1, Shrouk Ramadan2, Mohamed Saad Sayed3
1Faculty of Medicine, South Valley University, Qena, Egypt. Alaa.AbdRabbo@med.svu.edu.eg.
Naunyn-Schmiedeberg's archives of pharmacology
|November 18, 2025
概括
洛伦德罗斯塔特有效降低血压在不受控制的高血压. 虽然增加了电解质失衡的风险,但它显著减少了上腺功能不充分,这表明,在仔细监测下,安全性是有利的.
科学领域:
- 心血管医学 心血管医学
- 药理学 药理学是指药理学的学科.
- 临床试验 临床试验
背景情况:
- 失控的高血压仍然是一个重大的全球健康挑战.
- 选择性阿尔多氨酸合成酶抑制剂代表了一个新的治疗类.
- 需要对lorundrostat进行全面的疗效和安全性摘要.
研究的目的:
- 进行随机对照试验 (RCT) 的元分析.
- 评估洛伦德罗斯塔特在患有未控制高血压的患者的疗效和安全性.
- 综合现有关于lorundrostat临床益处和风险的证据.
主要方法:
- 按照PRISMA指南进行系统的文献搜索 (PubMed,Scopus,科学网).
- 包括与安慰剂相比较的RLT.
- 使用随机效应模型对血压变化和不良事件进行聚合分析.
主要成果:
- 洛伦德洛斯塔特显著降低了24小时系统血压 (MD: -6.65 mmHg) 和办公室系统血压 (MD: -7.94 mmHg).
- 观察到高血症 (RR: 5.47) 和低血症 (RR: 1.95) 的发病率增加.
- 显著降低上腺功能衰竭的风险 (RR: 0.15).
结论:
- 洛伦德洛斯塔特在降低无控高血压的血压方面表现出有效性.
- 安全性概况是可以接受的,需要监测电解质和功能.
- 选择性阿尔多氨酸合成酶抑制与lorundrostat可能提供一个有价值的治疗选择,特别是由于减少上腺功能不足的风险.
相关概念视频
01:30Hypertension III: Clinical Manifestations and Diagnostic Studies
451
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
451
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
895
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
895
01:28Hypertension IV: Drug Therapy and Lifestyle Modifications
595
Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
595
01:25Antihypertensive Drugs: Direct Renin Inhibitors
1.3K
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
1.3K
01:30Antihypertensive Drugs: Angiotensin II Receptor Blockers
2.4K
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
2.4K
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
2.3K
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
2.3K